Standardized Mean Difference in Baseline Characteristics of Adalimumab (ADA) and Tofacitinib (TOF) Treatment Groups Before and After Weighting
DISEASE
Error bars for disease activity score in 28 joints using C-reactive protein (DAS28-CRP) represent the minimum and maximum standardized mean difference values across 10 imputed data sets. The standardized mean difference is the difference between treatment groups in the mean for each covariate divided by its SD for the entire sample. The vertical dashed black lines indicate standardized mean differences of −0.03 and 0.03. ACT indicates Australian Capital Territory; NSW, New South Wales; QLD, Queensland and Western Australia; and TAS, Tasmania.